246 results on '"Lévy-Bruhl, Daniel"'
Search Results
2. What is the relevancy of a surveillance of mumps without a systematic laboratory confirmation in highly immunized populations? Epidemiology of suspected and biologically confirmed mumps cases seen in general practice in France between 2014 and 2020
3. Prices of paediatric vaccines in European vaccination programmes
4. Two-dose measles vaccine effectiveness remains high over time: A French observational study, 2017–2019
5. Invasive group A streptococcal disease in pregnant women and young children: a systematic review and meta-analysis
6. Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021–January 2022: A retrospective, population-based, matched cohort study
7. Influenza vaccination coverage of professionals working in nursing homes in France and related determinants, 2018–2019 season: a cross-sectional survey
8. Effect of change in vaccine schedule on pertussis epidemiology in France: a modelling and serological study
9. A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures
10. Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study
11. Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort
12. What is the relevancy of a surveillance of mumps without a systematic laboratory confirmation in highly immunized populations? Epidemiology of suspected and biologically confirmed mumps cases seen in general practice in France between 2014 and 2020
13. Monitoring the reproductive number of COVID-19 in France: Comparative estimates from three datasets
14. Unraveling the seasonal epidemiology of pneumococcus
15. Assessment of the MERS-CoV epidemic situation in the Middle East region
16. Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
17. Adherence and sustainability of interventions informing optimal control against the COVID-19 pandemic
18. Participatory Syndromic Surveillance of Influenza in Europe
19. Two-Dose Measles Vaccine Effectiveness Remains High Over Time: A French Observational Study, 2017-2019
20. Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France
21. Estimation de l’impact épidémiologique des niveaux de couverture vaccinale insuffisants en France
22. Towards a framework for evaluating and grading evidence in public health
23. Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020
24. 34. Politique vaccinale
25. Emergence of New Virulent Neisseria meningitidis Serogroup C Sequence Type 11 Isolates in France
26. Surveillance of Lower Respiratory Tract Infections Outbreaks in Nursing Homes in France
27. From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak
28. Influenza Vaccination Coverage of Healthcare Workers in Nursing Homes in France and Related Determinants, 2018- 2019 Season: A Cross-Sectional Survey
29. Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021
30. Influenza pandemic preparedness in France: modelling the impact of interventions
31. Apport de la modélisation mathématique à la décision vaccinale.: Illustrations avec les vaccinations contre la varicelle, le rotavirus et le papillomavirus
32. Vaccines: Specific Features, Simulation of Impact and Medico-Economic Modelling
33. Vaccins : spécificités, simulation de l’impact et modélisation médico-économique
34. Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population
35. Association between the COVID-19 pandemic and pertussis in France using multiple nationwide data sources
36. Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021
37. Adherence and sustainability of interventions informing optimal control against COVID-19 pandemic
38. Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
39. Seize années de surveillance des infections invasives bactériennes en France (1991-2006) à travers le réseau EPIBAC
40. Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings
41. Monitoring the proportion infected by SARS-CoV-2 from age-stratified hospitalisation and serological data
42. Impact of Vaccine Schedule Change on Pertussis Epidemiology in France: A Modelling and Serological Study
43. Invasive Group a Streptococcal Disease in Pregnant Women and Young Children Worldwide: Systematic Review and Meta-Analyses
44. Study of the risk factors for severe childhood pertussis based on hospital surveillance data
45. Early assessment of the impact of mitigation measures to control COVID-19 in 22 French metropolitan areas, October to November 2020
46. Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
47. BCG : attitudes actuelles
48. Diphtheria-Tetanus-Polio, Measles-Mumps-Rubella, and Hepatitis B Vaccination Coverage and Associated Factors among Homeless Children in the Paris Region in 2013: Results from the ENFAMS Survey
49. Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020
50. Tuberculosis treatment outcomes of notified cases: trends and determinants of potential unfavourable outcome, France, 2008 to 2014
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.